Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

NCS Multistage Holdings (NCSM) Research & Development (2024 - 2026)

NCS Multistage Holdings has reported Research & Development over the past 3 years, most recently at $587000.0 for Q1 2026.

  • For Q1 2026, Research & Development rose 2.09% year-over-year to $587000.0; the TTM value through Mar 2026 reached $2.4 million, up 13.01%, while the annual FY2025 figure was $2.4 million, 15.89% up from the prior year.
  • Research & Development for Q1 2026 was $587000.0 at NCS Multistage Holdings, down from $612000.0 in the prior quarter.
  • Over five years, Research & Development peaked at $656000.0 in Q3 2025 and troughed at $501000.0 in Q2 2024.
  • A 3-year average of $566333.3 and a median of $575000.0 in 2025 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: increased 20.15% in 2025 and later increased 2.09% in 2026.
  • Year by year, Research & Development stood at $531000.0 in 2024, then rose by 15.25% to $612000.0 in 2025, then decreased by 4.08% to $587000.0 in 2026.
  • Business Quant data shows Research & Development for NCSM at $587000.0 in Q1 2026, $612000.0 in Q4 2025, and $656000.0 in Q3 2025.